Ketoconazole in initial management and treatment of metastatic prostate cancer to spine

Mitchell H. Bamberger, Franklin C. Lowe

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Ketoconazole in high doses causes castrate levels of testosterone within twenty-four to forty-eight hours; therefore it is extremely useful in the initial medical treatment of patients with metastatic prostate cancer who need a prompt therapeutic response. Review of 17 patients who presented with severe radicular pain or acute paraparesis/paraplegia showed that there was frequent delay in urologic consultation, pathologic confirmation, and initiation of efficacious therapy. In fact, 5 of 12 patients (42%) who received radiation therapy prior to effective hormonal therapy suffered significant morbidity and mortality. The case is made for the use of ketoconazole for initial empirical therapy for these patients.

Original languageEnglish (US)
Pages (from-to)301-303
Number of pages3
JournalUrology
Volume32
Issue number4
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Ketoconazole
Prostatic Neoplasms
Spine
Paraparesis
Therapeutics
Paraplegia
Testosterone
Radiotherapy
Referral and Consultation
Morbidity
Pain
Mortality

ASJC Scopus subject areas

  • Urology

Cite this

Ketoconazole in initial management and treatment of metastatic prostate cancer to spine. / Bamberger, Mitchell H.; Lowe, Franklin C.

In: Urology, Vol. 32, No. 4, 1988, p. 301-303.

Research output: Contribution to journalArticle

@article{9f97ec1ef4b34fbe87908a78b31582d3,
title = "Ketoconazole in initial management and treatment of metastatic prostate cancer to spine",
abstract = "Ketoconazole in high doses causes castrate levels of testosterone within twenty-four to forty-eight hours; therefore it is extremely useful in the initial medical treatment of patients with metastatic prostate cancer who need a prompt therapeutic response. Review of 17 patients who presented with severe radicular pain or acute paraparesis/paraplegia showed that there was frequent delay in urologic consultation, pathologic confirmation, and initiation of efficacious therapy. In fact, 5 of 12 patients (42{\%}) who received radiation therapy prior to effective hormonal therapy suffered significant morbidity and mortality. The case is made for the use of ketoconazole for initial empirical therapy for these patients.",
author = "Bamberger, {Mitchell H.} and Lowe, {Franklin C.}",
year = "1988",
doi = "10.1016/0090-4295(88)90230-0",
language = "English (US)",
volume = "32",
pages = "301--303",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Ketoconazole in initial management and treatment of metastatic prostate cancer to spine

AU - Bamberger, Mitchell H.

AU - Lowe, Franklin C.

PY - 1988

Y1 - 1988

N2 - Ketoconazole in high doses causes castrate levels of testosterone within twenty-four to forty-eight hours; therefore it is extremely useful in the initial medical treatment of patients with metastatic prostate cancer who need a prompt therapeutic response. Review of 17 patients who presented with severe radicular pain or acute paraparesis/paraplegia showed that there was frequent delay in urologic consultation, pathologic confirmation, and initiation of efficacious therapy. In fact, 5 of 12 patients (42%) who received radiation therapy prior to effective hormonal therapy suffered significant morbidity and mortality. The case is made for the use of ketoconazole for initial empirical therapy for these patients.

AB - Ketoconazole in high doses causes castrate levels of testosterone within twenty-four to forty-eight hours; therefore it is extremely useful in the initial medical treatment of patients with metastatic prostate cancer who need a prompt therapeutic response. Review of 17 patients who presented with severe radicular pain or acute paraparesis/paraplegia showed that there was frequent delay in urologic consultation, pathologic confirmation, and initiation of efficacious therapy. In fact, 5 of 12 patients (42%) who received radiation therapy prior to effective hormonal therapy suffered significant morbidity and mortality. The case is made for the use of ketoconazole for initial empirical therapy for these patients.

UR - http://www.scopus.com/inward/record.url?scp=0023789792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023789792&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(88)90230-0

DO - 10.1016/0090-4295(88)90230-0

M3 - Article

VL - 32

SP - 301

EP - 303

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -